Share on Instagram  
Background Image

#iconohash presents #bcsm

Scroll down for the #bcsm conversation report for July 8th, 2018 EST.

iconohash

the world's conversation archive

#bcsm for July 8th, 2018EST

01
26th

coming together

When it comes to participants, we ranked 26th among 400 conversations.

26th

participating

In terms of the number of posts, we ranked 26th out of 400 conversations that took place.

13th

amplification

This conversation ranked 13th out of 400 in terms of the amplification of ideas & content.

how we participated. Here's how participants reacted & engaged each other

Reactions
70%

Amplified

There were 75 reshares, 70% of posts, during the course of the conversation.

0%

Engaged

0% of participants in this conversation engaged each other 0 times.

38%

Content

38% of participants in this conversation shared a total of 13 unique pieces of content.

quick facts.

Here are the basic facts of the conversation for for July 8th, 2018.

0
Active
Participants
0
Posts
Total

meet the influencers the movers and shakers of #bcsm

02

the top of the list. Top influencers in the chat

IMPACT
@OncLive

@OncLive

OncLive.com
Healthcare publisher of oncology focused journals, videos, panel discussions, and much more that run the gamut of oncology care and management.

@Liz_ORiordan

@Liz_ORiordan

Liz O'Riordan
Breast surgeon (with recurrent breast cancer), author, triathlete, motivational speaker, and wife (@dermotor)

@BreastAdvocate

@BreastAdvocate

Breast Advocate
Free #BreastCancer #Surgery #SharedDecisionMaking App for #Survivors, #Thrivers and #Previvors. Co-created by breast cancer specialists and patient advocates.

moving the conversation.

Without these participants, this conversation could not happen.

about the participants. let's take a look at everyone who show'd up

03

top professions what are they doing when they're not in #bcsm

insight

  the top participating professions
out of 22 total

director
writer
entrepreneur
founder
editor

gender an estimation of what the gender break down looks like
= 1 men or women

insight

Women

Men

about the content. the best content that was shared

04
Neratinib Approaches EU Approval for HER2+ Breast Cancer
The European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended approval of neratinib for the extended adjuvant treatment of adult patients with early stage hormone receptor–positive, HER2-overexpressed/amplified breast cancer following postoperative trastuzumab.

chat growth how is #bcsm growing over time?

05

want more? are you interested in the full data analysis for this chat? Full transcript? Longer view at chat growth?

Email us today at research@iconohash.com or schedule a tour of our custom reports. We'll be happy to work with you. We can provide the raw data or custom reports on a scheduled basis. Full data analysis includes in-depth profile data, chat growth analysis, chat reach, influence reach, location profiles, and content profiles. Full reports are delivered via sharable web-based reports or beautiful PDFs, if you prefer to print and distribute.